AC
RVMDW icon

Aristeia Capital’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Aristeia Capital’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-583,615
Closed -$1.03M – 863
2026
Q1 		$1.03M Sell
583,615
-41,320
-7% -$80K 0.02% 261
2025
Q4 		$572K Buy
624,935
+193,996
+45% +$109K 0.01% 304
2025
Q3 		$122K Buy
430,939
+117,908
+38% +$28.6K ﹤0.01% 414
2025
Q2 		$73.5K Sell
313,031
-6,100
-2% -$905 ﹤0.01% 407
2025
Q1 		$17K Hold
319,131
– – ﹤0.01% 388
2024
Q4 		$54.3K Buy
+319,131
New +$94.4K ﹤0.01% 311

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Aristeia Capital's RVMDW Position: Q2 2026 in Review

Aristeia Capital sold out of Revolution Medicines Inc Warrant (RVMDW) in Q2 2026, closing a stake of 583,615 shares — an estimated $1.03M sold.

Aristeia Capital first reported a position in RVMDW in Q4 2024 and held it in 6 quarters. The position peaked at $1.03M in Q1 2026. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • Aristeia Capital reported no remaining Revolution Medicines Inc Warrant position as of Q2 2026 after selling out during the quarter.
  • Aristeia Capital sold 583,615 Revolution Medicines Inc Warrant shares in Q2 2026, an estimated $1.03M.
  • Aristeia Capital first reported a position in Revolution Medicines Inc Warrant in Q4 2024 and held it in 6 quarters.
  • Aristeia Capital's Revolution Medicines Inc Warrant position peaked at $1.03M in Q1 2026.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.